Correction  by unknown
CORRECTIONS
In the article “ACCF/ASNC Appropriateness Criteria for Single-Photon Emission Computed Tomography Myocardial Perfusion
Imaging (SPECT MPI),” which appeared in the October 18, 2005 issue of the journal (Journal of the American College of Cardiology
2005:46:1587–1605), the following errors occurred:
• Table 7 (p. 1594): In the entry for Indications # 46 and # 47, the table lists “Less than 1 year after PCI.” In both instances this should
read as “Less than 2 years after PCI.”
• Table 10 (p. 1595): In the entry for Indication # 47, the table lists “Less than 1 year after PCI.” This should read as “Less than 2 years
after PCI.”
• Table 12 (p. 1598): In the entry for Indication # 46, the table lists “Less than 1 year after PCI.” This should read as “Less than 2 years
after PCI.”
Please see the corrected tables below.
Table 7. Risk Assessment: Post-Revascularization (PCI or CABG)
Indication
Appropriateness
Criteria
(Median Score)
Symptomatic
41. ● Evaluation of chest pain syndrome A (8.0)
Asymptomatic
42. ● Asymptomatic prior to previous
revascularization
● Less than 5 years after CABG
U (6.0)
43. ● Symptomatic prior to previous revascularization
● Less than 5 years after CABG
U (4.5)
44. ● Asymptomatic prior to previous
revascularization
● Greater than or equal to 5 years after CABG
A (7.5)
45. ● Symptomatic prior to previous revascularization
● Greater than or equal to 5 years after CABG
A (7.5)
46. ● Asymptomatic prior to previous
revascularization
● Less than 2 years after PCI
U* (6.5)
47. ● Symptomatic prior to previous revascularization
● Less than 2 years after PCI
I (3.0)
48. ● Asymptomatic prior to previous
revascularization
● Greater than or equal to 2 years after PCI
U* (6.5)
49. ● Symptomatic prior to previous revascularization
● Greater than or equal to 2 years after PCI
U (5.5)
*Median scores of 3.5 and 6.5 are rounded to the middle (Uncertain). Note: I (Inappropriate), U (Uncertain), and A
(Appropriate).
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Table 10. Inappropriate Indications (Median Rating of 1 to 3)
Indication
Appropriateness
Criteria
(Median Score)
Detection of CAD: Symptomatic—Evaluation of Chest Pain Syndrome
1. ● Low pre-test probability of CAD
● ECG interpretable AND able to exercise
I (2.0)
Detection of CAD Symptomatic—Acute Chest Pain (in Reference to Rest Perfusion Imaging)
8. ● High pre-test probability of CAD
● ECG: ST elevation
I (1.0)
Detection of CAD: Asymptomatic (Without Chest Pain Syndrome)
10. ● Low CHD risk (Framingham risk criteria) I (1.0)
Risk Assessment: General and Specific Patient Populations—
Asymptomatic
17. ● Low CHD risk (Framingham) I (1.0)
Risk Assessment With Prior Test Results: Asymptomatic OR Stable Symptoms—
Normal Prior SPECT MPI Study
21. ● Normal initial RNI study
● High CHD risk (Framingham)
● Annual SPECT MPI study
I (3.0)
Risk Assessment With Prior Test Results: Asymptomatic OR Stable Symptoms—
Abnormal Catheterization OR Prior SPECT MPI Study
23. ● Known CAD on catheterization OR prior SPECT MPI
study in patients who have not had revascularization
procedure
● Asymptomatic OR stable symptoms
● Less than 1 year to evaluate worsening disease
I (2.5)
Risk Assessment With Prior Test Results: Asymptomatic—
Prior Coronary Calcium Agatston Score
28. ● Agatston score less than 100 I (1.5)
Risk Assessment: Preoperative Evaluation for Non-Cardiac Surgery—
Low-Risk Surgery
31. ● Preoperative evaluation for non-cardiac surgery risk
assessment
I (1.0)
Risk Assessment: Preoperative Evaluation for Non-Cardiac Surgery—
Intermediate-Risk Surgery
32. ● Minor to intermediate perioperative risk predictor
● Normal exercise tolerance (greater than or equal to 4 METS)
I (3.0)
Risk Assessment: Preoperative Evaluation for Non-Cardiac Surgery—High Risk Surgery
36. ● Asymptomatic up to 1 year post normal catheterization,
non-invasive test, or previous revascularization
I (3.0)
Risk Assessment: Following Acute Coronary Syndrome STEMI—Hemodynamically Unstable,
Signs of Cardiogenic Shock, or Mechanical Complications
38. ● Thrombolytic therapy administered I (1.0)
Risk Assessment: Following Acute Coronary Syndrome—
Asymptomatic Post-Revascularization (PCI or CABG)
40. ● Routine evaluation prior to hospital discharge I (1.0)
Risk Assessment: Post-Revascularization (PCI or CABG)—Asymptomatic
47. ● Symptomatic prior to previous revascularization
● Less than 2 years after PCI
I (3.0)
Note: I (Inappropriate), U (Uncertain), and A (Appropriate).
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Table 12. Uncertain Indications (Median Rating of 4 to 6) (possibly appropriate indications that
should be reimbursed, but additional research and/or patient information is required during
updates of the criteria in order to rate them definitively as being appropriate)
Indication
Appropriateness
Criteria
(Median Score)
Detection of CAD: Symptomatic—
Evaluation of Chest Pain Syndrome
2. ● Low pre-test probability of CAD
● ECG uninterpretable OR unable to exercise
U* (6.5)
Detection of CAD: Asymptomatic (Without Chest Pain Syndrome)
11. ● Moderate CHD risk (Framingham) U (5.5)
Detection of CAD: Asymptomatic—
Valvular Heart Disease Without Chest Pain Syndrome
13. ● Moderate CHD risk (Framingham)
● To help guide decision for invasive studies
U (5.5)
Detection of CAD: Asymptomatic (Without Chest Pain Syndrome)—
New-Onset Atrial Fibrillation
14. ● Low CHD risk (Framingham)
● Part of the evaluation
U* (3.5)
Risk Assessment: General and Specific Patient Populations—
Asymptomatic
18. ● Moderate CHD risk (Framingham) U (4.0)
Risk Assessment With Prior Test Results: Asymptomatic—
CT Coronary Angiography
26. ● Stenosis of unclear significance U* (6.5)
Risk Assessment: Preoperative Evaluation for Non-Cardiac Surgery—
High-Risk Surgery
34. ● Minor perioperative risk predictor
● Normal exercise tolerance (greater than or
equal to 4 METS)
U (4.0)
Risk Assessment: Post-Revascularization (PCI or CABG)—
Asymptomatic
42. ● Asymptomatic prior to previous
revascularization
● Less than 5 years after CABG
U (6.0)
43. ● Symptomatic prior to previous revascularization
● Less than 5 years after CABG
U (4.5)
Risk Assessment: Post-Revascularization (PCI or CABG)—
Asymptomatic
46. ● Asymptomatic prior to previous
revascularization
● Less than 2 years after PCI
U* (6.5)
48. ● Asymptomatic prior to previous
revascularization
● Greater than or equal to 2 years after PCI
U* (6.5)
49. ● Symptomatic prior to previous revascularization
● Greater than or equal to 2 years after PCI
U (5.5)
*Median scores of 3.5 and 6.5 are rounded to the middle (Uncertain). Note: I (Inappropriate), U (Uncertain), and A
(Appropriate).
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